Trial Search Results
Immunobiology of Cancer
To learn whether or not an Interferon defect in cell signaling, recently discovered in immune cells from melanoma patients as well as breast cancer patients, is common to all cancers.
Stanford is currently not accepting patients for this trial.
Inclusion Criteria:Participants who have cancer or participants who do not have cancer
and/or an autoimmune disorder and are age 18 or over.
Exclusion Criteria:Participants who have an autoimmune disorder and/or are under the age of
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study